Company > Latest News

Latest News

IronUp

Yasoo Health introduces IronUp™

 

August 10, 2011

 

IronUp™ Liquid Iron Supplement was specifically formulated to supplement the levels of dietary iron for infants and children who do not receive adequate amounts in their diets.

Read More

Pharmarama becomes the exclusive UK distributor for AquADEKs line

March 1, 2010 – Borehamwood, UK - An agreement has been reached between Pharmarama International Limited and Yasoo Health Inc. for the exclusive UK distribution of Yasoo Health ’s AquADEKs® line of nutritional supplements designed to advance the standard of nutritional care for cystic fibrosis (CF) patients.
Read More

 

Yasoo Health Ltd’s E!INFLATREAT chosen as one of best practice research projects

May 12, 2009 -Yasoo Health Ltd, a subsidiary of Yasoo Health Inc., reported today that its Eureka research grant Ε!INFLATREAT was chosen as one of the 24 best practice research projects in a recent survey performed for the European 7th Framework Programme entitled “Use and Diffuse”(www.useanddiffuse.eu).  A total of 222 projects were surveyed to explore their dissemination and exploitation practices with innovation outputs. 

Read More

Yasoo Health introduces Syndion™
October 23, 2008 - Optimized nutritional support for neurodevelopmentally challenged children and adults with special nutritional needs and/or food sensitivities.

Read More

Yasoo Health Inc. Closes Series C Financing
August 18, 2008 – Yasoo Health Inc. (Yasoo) closes Series C Financing from Emergomed Limited. 
Read More

New help for people with CF or conditions that cause malabsorption of fat-soluble vitamins
April 23, 2007- Johnson City, TN Yasoo Health Inc announced the U.S. launch of AquADEKs®, a novel nutritional supplement designed to ...
Read More

Yasoo Health; a finalist in Nutracon
March 12, 2007- AquADEKs®, a product developed by Yasoo Health, was selected as one of the three finalists in the 2007 Nutracon Award Competition
Read More

Yasoo Health Ltd. is awarded a research grant from the Cyprus Research Promotion Foundation for its cancer chemoprevention research program
February 20, 2007 -Yasoo Health Ltd (Yasoo), a subsidiary of Yasoo Health Inc., reported today that it has been awarded a research grant from the Cyprus Research Promotion Foundation (RPF, www.research.org.cy) to support its research and development work on the identification and development of chemo-preventive products for the prevention and treatment of prostate cancer.
Read More

Yasoo Health Ltd. receives a research grant from the European organization EUREKA for its Inflammatory Bowel Disease Program
February 1, 2007 - Yasoo Health Ltd (Yasoo) announced today that it has secured a research grant from the European organization EUREKA (www.eureka.be) to support its research and development work on a product for the management and adjuvant therapy of Inflammatory Bowel Disease (IBD).
Read More

Yasoo Health, Inc. Receives Nearly $1 Million to Develop Novel Nutritional Formulation
February 7, 2006 - Yasoo Health, Inc. announced today that it received $936,375 in financing from the Cystic Fibrosis Foundation* to develop and commercialize a "first of its kind" formulation that addresses a key nutritional problem of poor fat-soluble vitamin and nutrient absorption in cystic fibrosis (CF) patients. 
Read More

Yasoo Health Awarded Patent
April 6, 2004 - Press Release -Yasoo Health, Inc announced today patent protection for a novel tocopherol ester derivative with selenium and other minerals.
Read More

Yasoo Health Inc. Closes Series A Financing
July 1, 2002 - Yasoo Health Inc. (Yasoo) closed Series A financing from the Bank of Cyprus Ventures and Emergo.
Read More

Yasoo Health Inc. Receives SBIR Grant
April 1, 2002 - Yasoo Health Inc. received funding from the NIH for a Small Business Innovation Research grant to develop formulations containing fat-soluble vitamins and nutrients (vitamins D3, K1 and mixed tocopherols (E), beta-carotene, linoleic and/or linolenic acids and coenzyme Q10) that will be administered to children with cystic fibrosis to alleviate complications due to the malabsorption of fat-soluble nutrients.
Read More